CausalSentinel

Protein Dossier — IL6ST (Interleukin-6 receptor subunit beta)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Forced vital capacity (FVC) -0.0178 0.00562 0.00151 Inverse variance weighted 4 cis NA
Forced vital capacity (FVC) -0.0178 0.00562 0.00151 Inverse variance weighted 4 trans NA
Forced vital capacity (FVC) -0.0178 0.00562 0.00151 Inverse variance weighted 4 trans NA
Forced vital capacity (FVC) -0.0178 0.00562 0.00151 Inverse variance weighted 4 trans NA
Ferritin 0.0887 0.0371 0.0169 Inverse variance weighted 3 trans NA
Ferritin 0.0887 0.0371 0.0169 Inverse variance weighted 3 trans NA
Ferritin 0.0887 0.0371 0.0169 Inverse variance weighted 3 trans NA
Forced expiratory volume in 1-second (FEV1) -0.0138 0.00592 0.02 Inverse variance weighted 4 cis NA
Forced expiratory volume in 1-second (FEV1) -0.0138 0.00592 0.02 Inverse variance weighted 4 trans NA
Forced expiratory volume in 1-second (FEV1) -0.0138 0.00592 0.02 Inverse variance weighted 4 trans NA
Forced expiratory volume in 1-second (FEV1) -0.0138 0.00592 0.02 Inverse variance weighted 4 trans NA
Ovarian cancer 0.0851 0.0375 0.023 Inverse variance weighted 4 cis NA
…and 361 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2620_4_2 gp130, soluble Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

44 association rows across 20 traits (32 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
IL6ST protein levels 2e-174 rs62363865 2 GCST90469603 no MR -> candidate analysis
Interleukin-6 receptor subunit beta levels 5e-114 rs11739016 4 GCST90248077 no MR -> candidate analysis
IL31RA protein levels 2e-63 rs13168372 6 GCST90469589 no MR -> candidate analysis
Height 8e-30 rs1373998 3 GCST90245848 MR: beta=0.0144, p=0.364 (trans)
Serum levels of protein IL6ST 1e-29 rs7726239 1 GCST90087986 no MR -> candidate analysis
Interleukin-6 receptor subunit beta levels (IL6ST.2620.4.2) 1e-22 rs11574765 1 GCST90241649 no MR -> candidate analysis
Blood protein levels 3e-20 rs10471960 1 GCST006585 no MR -> candidate analysis
Interleukin-6 receptor subunit beta level in Chronic kidney 6e-14 rs13183065 1 GCST90237020 no MR -> candidate analysis
Height (baseline) 7e-14 rs9791086 2 GCST90565843 no MR -> candidate analysis
IgG glycosylation 7e-11 rs17348299 13 GCST001848 no MR -> candidate analysis
Body size or adipose distribution (multivariate analysis) 3e-10 rs6870870 1 GCST90624105 no MR -> candidate analysis
Mean spheric corpuscular volume 5e-10 rs199666144 1 GCST90002397 no MR -> candidate analysis
…and 8 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1738 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Autosomal recessive hyper-IgE syndrome 0.824 established (curated) no MR -> candidate analysis
Stuve-Wiedemann syndrome 2 0.763 established (curated) no MR -> candidate analysis
hyper-IgE recurrent infection syndrome 4A, autosomal dominant 0.779 established (curated) no MR -> candidate analysis
immunodeficiency 94 with autoinflammation and dysmorphic facies 0.698 established (curated) no MR -> candidate analysis
Stuve-Wiedemann syndrome 0.547 established (curated) no MR -> candidate analysis
genetic developmental and epileptic encephalopathy 0.509 established (curated) no MR -> candidate analysis
alcohol drinking 0.5 common-variant locus no MR -> candidate analysis
stroke disorder 0.45 common-variant locus no MR -> candidate analysis

Of the 8 rows above, 8 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Interleukin-6 receptor subunit beta)
gnomAD constraint pLI=1, LOEUF=0.37 — LoF-INTOLERANT
GWAS Catalog 43 unique SNPs / 86 rows
ClinVar 663 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance